Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | News
Search Refinements

Contract Services News

View news from other Pharmaceutical sectors:
61-75 of 2352 results
GSK licenses intellectual property for respiratory disease target identified using Five Prime's platform
Five Prime Therapeutics announced that GSK exercised its option to take an exclusive license to the intellectual property related to a target under the respiratory diseases research collaboration between the companies, triggering a $1.5m license payment to Five Prime.
Contract Research & Services > Contract Services > News
RedHill Biopharma announces research collaboration with NIH for potential Ebola treatment
RedHill Biopharma signed a research collaboration agreement with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), intended to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.
Contract Research & Services > Contract Services > News
Amgen, Daiichi Sankyo sign deal to commercialize biosimilars in Japan
Amgen and Daiichi Sankyo Company have signed an exclusive agreement to commercialize nine biosimilars in Japan.
Contract Research & Services > Contract Services > News
Aphios secures subcontract for nanoformulation of super hydrophobic anticancer drug
Aphios has been awarded a subcontract for the nanoformulation of a super hydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, MD.
Contract Research & Services > Contract Services > News
Cantabio signs deal with PRF to advance development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates
Cantabio Pharmaceuticals has signed an agreement with Purdue Research Foundation (PRF) to advance the company’s development work on targeting DJ-1 protein small molecule pharmaceutical chaperone drug candidates for the treatment of Parkinson’s Disease (PD) and other related neurodegenerative diseases.
Contract Research & Services > Contract Services > News
BioInvent forms process development and manufacturing collaboration with Alligator
BioInvent International has signed an agreement with Alligator Bioscience to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
Contract Research & Services > Contract Services > News
TiGenix licenses ex-US rights for Cx601 stem cell treatment to Takeda
By PBR Staff Writer
TiGenix has sold to Takeda Pharmaceutical ex-US rights to its stem cell treatment Cx601 for complex perianal fistulas in patients with Crohn's disease.
Contract Research & Services > Contract Services > News
IntelGenx, RedHill Biopharma sign deal with Grupo Juste for commercialization of RIZAPORT
IntelGenx and RedHill Biopharma signed a definitive agreement with Grupo Juste for the commercialization of RIZAPORT, a unique oral thin film for the treatment of acute migraines, in the country of Spain.
Contract Research & Services > Contract Services > News
Aeterna Zentaris, Orient EuroPharma sign exclusive license deal for Zoptrex in Taiwan and Southeast Asia
Aeterna Zentaris has signed an exclusive license agreement with Cyntec, an affiliate of OEP (“Cyntec”), for its lead anti-cancer compound, Zoptrex (zoptarelin doxorubicin), for the initial indication of endometrial cancer, for Taiwan and nine countries in Southeast Asia (the “Territory”).
Contract Research & Services > Contract Services > News
BIND Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer
BIND Therapeutics has filed a motion for court approval of a stalking horse asset purchase agreement bid from Pfizer for the purchase of the majority of BIND's assets.
Contract Research & Services > Contract Services > News
Clinigen, Horizon Pharma partner to start European Managed Access program for RAVICTI Oral Liquid
Clinigen Group's Idis Managed Access (MA) division and Horizon Pharma have initiated a Managed Access program in Europe for Horizon’s RAVICTI (glycerol phenylbuterate) Oral Liquid.
Contract Research & Services > Contract Services > News
Therapix signs binding MOU with Swiss pharmaceutical firm to receive License to use formulation for ultralow-dosage administration
Therapix Biosciences has entered into a binding memorandum of understandings with a Swiss pharmaceutical development company, to receive a worldwide and exclusive license to use the formulation for sublingual administration of ultralow dosages of THC, for the purpose of developing and marketing the formulation in the indications on which the Company has chosen to focus, with an emphasis on cognitive impairments.
Contract Research & Services > Contract Services > News
Rich Pharmaceuticals retains Theradex Systems to help advance Hodgkin's Lymphoma indication
Rich Pharmaceuticals has entered into an additional agreement with Theradex Systems to assist it in submitting a protocol to the US FDA for Hodgkin's Lymphoma under the company's existing Investigational New Drug Application (IND).
Contract Research & Services > Contract Services > News
Impax Laboratories to buy generic products from Teva and Allergan for $586m
By PBR Staff Writer
Impax Laboratories has agreed to acquire a portfolio of generic drugs from Teva Pharmaceutical Industries and Allergan for about $586m.
Contract Research & Services > Contract Services > News
Cipher Pharmaceuticals out-licenses rights to ASF-1096 for anorectal disorders
Cipher Pharmaceuticals announced that Edesa Biotech has licensed the rights to ASF-1096 (R-salbutamol) for use in anorectal disorders.
Contract Research & Services > Contract Services > News
61-75 of 2352 results